Thomas P. Schnettler - Dec 13, 2022 Form 4 Insider Report for Akoya Biosciences, Inc. (AKYA)

Role
Director
Signature
/s/ Thomas P. Schnettler, by Brian McKelligon, as Attorney-in-Fact
Stock symbol
AKYA
Transactions as of
Dec 13, 2022
Transactions value $
-$925,782
Form type
4
Date filed
12/20/2022, 03:02 PM
Previous filing
Jun 3, 2022
Next filing
May 19, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKYA Common Stock Sale -$926K -71.1K -2.53% $13.03 2.74M Dec 13, 2022 Held by Piper Sandler Merchant Banking Fund II, L.P. F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 PSC Capital Management II LLC is the general partner of Piper Sandler Merchant Banking Fund II, L.P. Piper Sandler Companies is the manager of PSC Capital Management II LLC. The reporting person is the Co-CEO of PSC Capital Management II LLC and disclaims beneficial ownership of the shares held by Piper Sandler Merchant Banking Fund II, L.P.